Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants
Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants in an Observational Study
IRCCS Azienda Ospedaliero-Universitaria di Bologna
120 participants
Jan 7, 2025
OBSERVATIONAL
Conditions
Summary
The present study is therefore aimed at investigating the prevalence of hepatic alterations (laboratory and imaging) in adult patients with TS and generating hypothesissto the possible etiopathogenetic factors most involved, as well as evaluating the correlation between biochemical and structural abnormalities. Thus, the study could provide relevant etiopathogenetic and prognostic results on the development of hepatopathy in TS patients.
Eligibility
Inclusion Criteria3
- Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood.
- Age 18 years or older
- Written informed consent obtained
Exclusion Criteria1
- TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA).
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06794190